New research shows positive experiences may boost the brain’s energy transformation, possibly building resilience against brain disorders in later life.
People with a history of cognitively stimulating occupations during their 30s, 40s, 50s, and 60s had a lower risk of mild cognitive impairment and dementia after age 70.
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
A study led by Columbia neurosurgeons has found that MRI-guided laser ablation is a viable treatment that can provide lasting seizure control for people with drug-resistant temporal lobe epilepsy.
A new study in mice shows that new neurons created in the brain during adulthood are needed to maintain working memory—the temporary “sticky notes” of the brain.
Many researchers believe that the neurodegenerative disorder gets started in the gut. Columbia research now suggests that an autoimmune reaction may be driving those early events.
Columbia researchers have identified brain circuits that, when injured, make conscious patients with acute brain injury appear unresponsive, a phenomenon known as hidden consciousness.
Lecanemab, marketed as Leqembi, is the first drug for Alzheimer’s disease to receive approval on the basis of clinically slowing the progression of Alzheimer’s disease.
A study of professionals in the National Hockey League found that players who frequently engaged in fighting on the ice died a decade earlier than less pugilistic players.
Age-related memory loss is caused, in part, by lack of flavanols—nutrients found in certain fruits and vegetables—according to a large study in older adults.